Implants containing combretastatin a-4

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050065595A1
SERIAL NO

10488515

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The subject matter of this invention relates to implants, in particular intracavernous or intravascular implants, preferably for use in the treatment or prophylaxis of coronary or peripheral vascular occlusions or vascular narrowings or stenoses, in particular for use in the prophylaxis of a restenosis, which implants contain CA4 or CA4P in a chemically covalently or noncovalently bonded or a physically fixed form, and methods for the production and application thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHAPLIN DAVIDNot Provided

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chaplin, David Watlington, GB 12 46
Kuttler, Bernd Reutlingen, DE 3 139
Lorenz, Gunter Tubingen, DE 6 119
Wnendt, Stephan Aachen, DE 24 512

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation